feature2

Enable expects that there will be over 250 biologic candidates for the device within the next 10 years. The device has several unique features, one of the most important being the ability to use product immediately after transfer from a refrigerator. While the technology is pre-FDA, Enable maintains an existing relationship with the organization and expects to be the first company in the country to complete clinicals and receive FDA approval with this type of technology.

According to Gotsch, CEO of Partnership for New York, “New York uniquely produces more innovative medical technology than any other region, but it lags in new company formation.” There are dozens of emerging breakthrough technologies in which significant enterprises could be built, but no CEOs to take the lead. These projects are capable of getting the funding and resources necessary to get off the ground, but are desperate for CEOs and entrepreneurs experienced enough to take ideas from the lab into full fruition

Interface focuses on combinatioScreen Shot 2014-11-21 at 5.13.19 PMn products, most specifically for PICCs, ports, and catheters. Interface has developed an anti-thrombogenic device and a combination drug delivery device, which can be utilized in a range of clinical fields including cardiology, urology, radiology, oncology, and orthopedics.

Laparoscopic procedures conducted with the EndoSphere Surgical system are immensely easier, and can be done in an environment with significantly lowered pressure. Mr. Prenovitz described the new system as being easier for surgeons, especially those 45 and under – as they have played more interactive video games than their older colleagues! Interestingly enough, the concept of virtually entering a person’s body and conducting surgery uses similar coordination and spatial understanding as many computer-simulated games.

OneMedForum – for the first time – will offer a general exhibit area to showcase poster displays on all presenting companies as well as exhibits featuring new tools and technologies for emerging healthcare companies. Exhibits will focus on innovative solutions and will include equity funding portals, online databases, research services, and valuation services, among many others. The conference exhibit area will also provide a general networking space for CEOs and investors.

The 8th Annual OneMedForum reports new features for its January conference. In addition to a central and spacious venue at the Marriott Marquis, OneMedForum continues to develop some key programs to strengthen its capital raising platforms and business development.

OneMedMarket is pleased to report that its member company Epion Health announced the closing of a $4.5M Series A financing round with Deerfield Management Company, a leading national venture fund.